Second-Generation Drug-Eluting Stents in Diabetes (SUGAR) trial: Rationale and study design
ConclusionsSUGAR is the first randomized head-to head trial comparing second-generation DES in an all-comer diabetic population undergoing PCI.
Source: American Heart Journal - Category: Cardiology Source Type: research
More News: Angioplasty | Cardiology | Cardiovascular | Coronary Angioplasty | Diabetes | Diabetes Mellitus | Endocrinology | Heart | Heart Attack | Percutaneous Coronary Intervention | Spain Health | Study | Sugar